☆ 4.7 Letter

Sharing of Data From Industry-Funded Registered Clinical Trials

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Volume 315, Issue 24, Pages 2729-2730

Publisher

AMER MEDICAL ASSOC

DOI: 10.1001/jama.2016.6310

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Multidisciplinary Sciences

Changes in key recruitment performance metrics from 2008-2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov

Mette Brogger-Mikkelsen, John Robert Zibert, Anders Daniel Andersen, Ulrik Lassen, Merete Haedersdal, Zarqa Ali, Simon Francis Thomsen

Summary: The aim of this study was to quantify recruitment performance in industry-sponsored phase III clinical trials conducted globally from 2008 to 2019. The results showed that recruitment duration and the number of registered sites per clinical trial have increased significantly, while the number of participants enrolled in clinical research has decreased. These findings suggest that recruitment for phase III clinical trials is less effective today compared to 12 years ago.

PLOS ONE (2022)

Add to Collection

Letter Medicine, General & Internal

Analysis of Registered Clinical Trials in Gastroenterology, 2007-2019

Nirosha D. Perera, Marija Kamceva, Jolie Z. Shen, Brandon E. Turner, Maya Abdou, Jecca R. Steinberg, Amit Mahipal

Summary: This study examines the relationship between gastrointestinal clinical trial characteristics and early discontinuation, result reporting, and methodological rigor from 2007 to 2019.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Management

Bridging the gap between invention and innovation: Increasing success rates in publicly and industry-funded clinical trials

Carolin Haeussler, Anne Assmus

Summary: This research highlights the importance of having both basic and applied scientific skills and experience in multiple fields for successful translation from discoveries to products. There are nuanced differences in how these qualities impact publicly funded and industry-funded trials.

RESEARCH POLICY (2021)

Add to Collection

Review Medicine, General & Internal

Status, use and impact of sharing individual participant data from clinical trials: a scoping review

Christian Ohmann, David Moher, Maximilian Siebert, Edith Motschall, Florian Naudet

Summary: The study found that while there is a high willingness to share IPD data from clinical trials, the actual data-sharing rates are suboptimal, and journals have poor to moderate enforcement of data-sharing policies. When data is requested, it is more often for secondary analysis and meta-analysis, rather than re-analysis. Studies on the real impact of data-sharing are rare and often use surrogate metrics like citation metrics.

BMJ OPEN (2021)

Add to Collection

Article Medicine, Research & Experimental

Ethics challenges in sharing data from pragmatic clinical trials

Stephanie R. Morain, Juli Bollinger, Kevin Weinfurt, Jeremy Sugarman

Summary: Sharing data in pragmatic clinical trials presents ethical challenges, such as waivers of informed consent, risks for patient-subjects and health systems, use of electronic health records, and limited control over sensitive data. These challenges raise questions about the suitability of traditional research ethics governance structures.

CLINICAL TRIALS (2022)

Add to Collection

Article Chemistry, Medicinal

Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases

Huan Zhang, Cheng Yu, Yuanling Cheng, Zhi Chen, Min Chen, Wangan He, Zhigang Jin, Shaoqian Cai, Lijuan Yu

Summary: The number of clinical trials investigating therapeutic interventions for HCM has increased in recent years. These trials generally did not incorporate randomized controlled trials or masking and were small studies recruiting fewer than 50 participants. Targeting myosin-7 has been the focus of recent research, but the molecular signaling mechanisms involved in the pathogenesis of HCM have the potential to elucidate novel target pathways.

DRUG DESIGN DEVELOPMENT AND THERAPY (2023)

Add to Collection

Review Oncology

The characteristics of registered acupuncture clinical trials enrolling cancer patients

Ming Jin, Lulu Xie, Ni Mao, Jianzi Wei, Junchao Chen, Xuefen Chen, Huijuan Mao

Summary: This study identified 222 eligible trials from 19 countries, encompassing 17 specific cancer types and 32 symptoms. The most common cancer types included breast cancer, head and neck cancer, colorectal cancer, lung cancer, and gastric cancer, accounting for almost half of all registered trials (48.2%). The top five symptoms included chemotherapy-induced peripheral neuropathy (CIPN), cancer-related pain, cancer-related fatigue, chemotherapy-induced nausea and vomiting (CINV), and gastrointestinal dysfunction.

SUPPORTIVE CARE IN CANCER (2022)

Add to Collection

Article Nanoscience & Nanotechnology

Clinical Trials of Liposomes in Children's Anticancer Therapy: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov

Zhaosong Feng, Yuyang Gu, Mengping Yuan, Renzhong Xiao, Zhenghua Fei

Summary: This study aimed to synthesize current findings from clinical trials of liposomes in children's anticancer therapy (LCAT) listed on ClinicalTrials.gov. The results showed that most of the trials were non-randomized, single group assignment, and non-blinded interventional trials of small scale, focusing on organic chemicals, with leukemia, lymphoma, and ovarian cancer being the main diseases studied.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)

Add to Collection

Article Clinical Neurology

Recruitment across two decades of NIH-funded Alzheimer's disease clinical trials

Marina Ritchie, Daniel L. Gillen, Joshua D. Grill

Summary: This study analyzed the recruitment trends of 11 Alzheimer's disease clinical trials conducted over a 20-year period. The study found that there were no significant changes in recruitment planning or overall recruitment rates over time. None of the trials achieved a recruitment rate of more than one participant per site per month. Trials with no competition had the fastest recruitment rates, while trials that overlapped in time had the slowest rates. The study suggests that recruitment projections should plan for less than one participant per site per month and consider the number of other trials being conducted concurrently.

ALZHEIMERS RESEARCH & THERAPY (2023)

Add to Collection

Article Medicine, General & Internal

Characteristics of Depression Clinical Trials Registered on ClinicalTrials.gov

Juan Liang, Peijie He, Hanting Wu, Xiujuan Xu, Conghua Ji

Summary: The study found that depression clinical trials registered on ClinicalTrials.gov mainly had small sample sizes and lacked trials related to COVID-19. The choice of study design is crucial, and properly designed trials can help improve study efficiency and reduce the likelihood of study failure. With the increase in the number of randomized controlled trials, the quality of trials is gradually improving. Additionally, more scientific attention is needed for depression trials focusing on children and older adults.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Practical guidance for planning resources required to support publicly-funded adaptive clinical trials

James M. S. Wason, Munyaradzi Dimairo, Katie Biggs, Sarah Bowden, Julia Brown, Laura Flight, Jamie Hall, Thomas Jaki, Rachel Lowe, Philip Pallmann, Mark A. Pilling, Claire Snowdon, Matthew R. Sydes, Sofia S. Villar, Christopher J. Weir, Nina Wilson, Christina Yap, Helen Hancock, Rebecca Maier

Summary: Adaptive designs are a method to improve the efficiency and patient benefit of clinical trials, but there are barriers to their widespread use, including a lack of understanding about resource requirements. The Costing Adaptive Trials project provides guidance and a costing tool to address this issue, along with recommendations for trial funders.

BMC MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

Osteoporosis-Related Randomized Clinical Trials With Middle-Aged and Older Adults Registered on the International Clinical Trials Registry Platform

Fenghua Lai, Ling Pei, Xinwen Chen, Jin Li

Summary: The study identified that RCTs on osteoporosis in middle-aged and older adults were mainly focused on women and had treatment as the primary purpose. Most trials used an open-label design and lacked available results and associated publications. Prospective registration and blinding design awareness in osteoporosis-related RCTs is needed, along with promotion of publication and dissemination of results.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Obstetrics & Gynecology

Exclusion of pregnant and lactating persons from breast cancer clinical trials: a review of active trials registered on

Amy Metcalfe, Nikki Stephenson, Zoe F. Cairncross, Natalie V. Scime, Miranda Fidler-Benaoudia

Summary: Treatment of pregnancy-associated breast cancer is complex and requires balancing the risks to the pregnant person and the developing fetus. However, pregnant and lactating people are traditionally excluded from randomized controlled trials, resulting in evidence gaps in treatment for this population. A study was conducted to review the inclusion/exclusion criteria of current breast cancer trials and assess the proportion that allowed enrollment of pregnant and lactating persons.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2023)

Add to Collection

Article Pharmacology & Pharmacy

Registered Clinical Trials Comprising Pregnant Women in China: A Cross-Sectional Study

Yi Zhao, Guiping Du, Xiaofei Luan, Hui Yang, Qiongguang Zhang, Zhengfu Zhang, Subiao Wang

Summary: This study investigated the clinical drug trials involving pregnant women in China, revealing a significant shortage of development, evaluation, and safety trials for pregnancy-related drugs. Modifying legislation and providing financial incentives may encourage pharmaceutical companies to conduct more clinical trials on pregnant women.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Letter Medicine, General & Internal

Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19

Laura C. Esmail, Philipp Kapp, Rouba Assi, Julie Wood, Gabriela Regan, Philippe Ravaud, Isabelle Boutron

Summary: This study examines the consistency between the intent to share data reported in registries, publications, or preprints and the actual access to individual patient-level data from randomized clinical trials during the COVID-19 pandemic.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Article Health Care Sciences & Services

Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19

Olivier Pierre, Carolina Riveros, Sarah Charpy, Isabelle Boutron

Summary: The study assessed the sensitivity of two secondary electronic sources of COVID-19 studies, with the L.OVE platform showing better performance in identifying research reports.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2022)

Add to Collection

Article Respiratory System

Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group

Olivier Hermine, Xavier Mariette, Raphael Porcher, Matthieu Resche-Rigon, Pierre-Louis Tharaux, Philippe Ravaud

Summary: This study aimed to determine whether anti-interleukin (IL)-6 receptors improve outcomes in critically ill patients with COVID-19 pneumonia. The results showed that anti-IL-6 receptor treatment did not significantly increase the number of patients alive without the need for noninvasive ventilation (NIV) or mechanical ventilation (MV) by day 14.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Health Care Sciences & Services

Acceptability of and Willingness to Take Digital Pills by Patients, the Public, and Health Care Professionals: Qualitative Content Analysis of a Large Online Survey

Astrid Chevance, Axel Fortel, Adeline Jouannin, Faustine Denis, Marie-France Mamzer, Philippe Ravaud, Stephanie Sidorkiewicz

Summary: Digital pills face limitations in prospective acceptability and willingness to use, primarily due to clinical and ethical concerns. Results indicate that willingness to take digital pills is associated with gender and the current use of connected devices to record health settings.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Add to Collection

Article Health Care Sciences & Services

Patients' Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based Survey

Van Thu Nguyen, Philippe Ravaud, Viet Thi Tran, Bridget Young, Isabelle Boutron

Summary: The study investigates patients' preferences for the organization of randomized controlled trials (RCTs) and finds that most patients prefer a hybrid model involving both on-site and remote visits. Patients are more likely to participate in a trial organized according to their preferences.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Add to Collection

Editorial Material Health Care Sciences & Services

The Global Evidence Commission?s report provided a wake-up call for the evidence community

Ruth Stewart, Isabelle Boutron, Elie A. Akl

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Add to Collection

Article Health Care Sciences & Services

Intervention effect estimates in randomised controlled trials conducted in primary care versus secondary or tertiary care settings: a meta-epidemiological study

Amandine Dugard, Elsa Tavernier, Agnes Caille, Agnes Dechartres, Adeline Hoang, Bruno Giraudeau, Clarisse Dibao-Dina

Summary: The study compared intervention effect estimates between primary care setting randomized controlled trials (PC-RCTs) and secondary or tertiary care setting randomized controlled trials (ST-RCTs) and found no significant difference. However, the medical fields represented in the study were not representative of the pathologies encountered in primary care, suggesting the need for further research.

BMC MEDICAL RESEARCH METHODOLOGY (2022)

Add to Collection

Article Health Care Sciences & Services

Considering multiple outcomes with different weights informed the hierarchy of interventions in network meta-analysis

Dimitris Mavridis, Adriani Nikolakopoulou, Irini Moustaki, Anna Chaimani, Raphael Porcherd, Isabelle Boutron, Philippe Ravaud

Summary: This study presents graphical methods to group interventions and uses conjoint analysis to place weights on outcomes based on stakeholders' preferences. The results provide valuable information about the clustering of interventions. Grouping interventions helps decision makers identify optimal options in terms of benefit-risk balance and choose interventions from the best cluster based on other factors such as cost and implementation.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

A methodological review with meta-epidemiological analysis of preclinical systematic reviews with meta-analyses

Noemie Simon-Tillaux, Anne-Laure Gerard, Deivanes Rajendrabose, Florence Tubach, Agnes Dechartres

Summary: This study aimed to evaluate the methodological quality and effect size relationship in systematic reviews with meta-analyses of preclinical studies published recently. The results showed that although there have been improvements in the methodological characteristics of recent studies, the methodological quality of included studies remains poor and there is no evidence of a potential association between study methodological characteristics and effect size.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Usefulness of serum procalcitonin and point-of-care multiplex PCR gastro-intestinal panel in acute diarrhoea or colitis in the emergency department

Marta Cancella de Abreu, Clementine Cassard, Ilaria Cherubini, Enfel Houas, Agnes Dechartres, Pierre Hausfater

Summary: This study aims to describe the procalcitonin (PCT) concentrations in patients with acute infectious diarrhoea. The results show that PCT remains low when a bacteria is identified in patients with acute infectious diarrhoea, suggesting that it may not be informative in guiding antibiotic therapy.

BIOMARKERS (2023)

Add to Collection

Article Mathematical & Computational Biology

metaCOVID: A web-application for living meta-analyses of COVID-19 trials

Theodoros Evrenoglou, Isabelle Boutron, Georgios Seitidis, Lina Ghosn, Anna Chaimani

Summary: Outputs from living evidence syntheses projects have been widely used during the pandemic to provide evidence-based recommendations. However, stakeholders also need to understand the data and perform their own exploratory analyses. To assist them, a metaCOVID application has been created in R to facilitate fast data exploration and tailored sub-analyses.

RESEARCH SYNTHESIS METHODS (2023)

Add to Collection

Article Health Care Sciences & Services

No evidence of important difference in summary treatment effects between COVID-19 preprints and peer-reviewed publications: a meta-epidemiological study

Mauricia Davidson, Theodoros Evrenoglou, Carolina Grana, Anna Chaimani, Isabelle Boutron

Summary: This study evaluated the difference in summary treatment effect estimates between preprint and peer-reviewed journal trials in the context of COVID-19. The results showed that there was no significant difference in summary effect estimates between preprint and peer-reviewed journal trials.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Add to Collection

Review Health Care Sciences & Services

A structured approach to information retrieval improved identification of funding and researchers' conflicts of interest in trials included in Cochrane reviews

Erlend Faltinsen, Adnan Todorovac, Isabelle Boutron, Lesley A. Stewart, Asbjorn Hrobjartsson, Andreas Lundh

Summary: The study compares the contemporary Cochrane review approach with a structured approach for retrieving information on trial funding and researchers' conflicts of interest, and finds that the structured approach is more effective in obtaining this information.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Add to Collection

Article Dermatology

cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults

Laura Fertitta, Kavita Y. Sarin, Christina Bergqvist, Ekshika Patel, Bastien Peiffer, Sabine Moryousef, Marie-Laure Armand, Arnaud Jannic, Salah Ferkal, Philippe Ravaud, Viet-Thi Tran, Jaishri O. Blakeley, Carlos G. Romo, Khaled Ezzedine, Pierre Wolkenstein

Summary: This study first defined severity strata for cutaneous neurofibromas using an anchoring approach. After validation in French and United States populations, the cNF-Skindex and the strata showed a strong correlation in interpreting cutaneous neurofibromas in daily practice and clinical trials.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group

Olivier Hermine, Xavier Mariette, Raphael Porcher, Felix Djossou, Yann Nguyen, Jean-Benoit Arlet, Laurent Savale, Jean Luc Diehl, Sophie Georgin-Lavialle, Jacques Cadranel, Gilles Pialoux, Karine Lacombe, Arsene Mekinian, Helene Gros, Xavier Lescure, Jade Ghosn, Elisabeth Coupez, Kevin Grapin, Christophe Rapp, Marc Michel, Anne Lise Lecapitaine, Jean Marie Michot, Nathalie Costedoat-Chalumeau, Liem Binh Luong Nguyen, Luca Semerano, Francois Raffi, Claire Aguillar, Claire Rouzaud, Jacques Eric Gottenberg, Yves Hansmann, Boris Bienvenu, Jonathan London, Franklin Samou Fantchou, Felix Ackermann, Antoine Gros, Alexandre Morel, Nicolas Gambier, Damien Sene, Bruno Megarbane, Elie Azoulay, Serge Bureau, Maxime Dougados, Joseph Emmerich, Muriel Fartoukh, Bertrand Guidet, Marc Humbert, Mathieu Mahevas, Frederic Pene, Frederic Schlemmer, Valerie Pourcher-Martinez, Annick Tibi, Gabriel Baron, Elodie Perrodeau, Stephanie Baron, Gabriel Steg, Yazdan Yazdapanah, Tabassome Simon, Matthieu Resche-Rigon, Pierre-Louis Tharaux, Philippe Ravaud

Summary: The combination of dexamethasone and tocilizumab did not improve the need for mechanical ventilation and mortality in patients with moderate-to-severe COVID-19 pneumonia. The safety of both treatments was similar.

ECLINICALMEDICINE (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.